|
1
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
Di Meco F, et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ladomersky E, Scholtens DM, Kocherginsky
M, Hibler EA, Bartom ET, Otto-Meyer S, Zhai L, Lauing KL, Choi J,
Sosman JA, et al: The coincidence between increasing age,
immunosuppression, and the incidence of patients with glioblastoma.
Front Pharmacol. 10:2002019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Gittleman H, Truitt G, Boscia
A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2011–2015. Neuro Oncol. 20 (Suppl 4):iv1–iv86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harder BG, Blomquist MR, Wang J, Kim AJ,
Woodworth GF, Winkles JA, Loftus JC and Tran NL: Developments in
blood-brain barrier penetrance and drug repurposing for improved
treatment of glioblastoma. Front Oncol. 8:4622018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shergalis A, Bankhead A III, Luesakul U,
Muangsin N and Neamati N: Current challenges and opportunities in
treating glioblastoma. Pharmacol Rev. 70:412–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Van Tellingen O, Yetkin-Arik B, De Gooijer
MC, Wesseling P, Wurdinger T and de Vries HE: Overcoming the
blood-brain tumor barrier for effective glioblastoma treatment.
Drug Resist Updat. 19:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minniti G, Muni R, Lanzetta G, Marchetti P
and Enrici RM: Chemotherapy for glioblastoma: Current treatment and
future perspectives for cytotoxic and targeted agents. Anticancer
Res. 29:5171–5184. 2009.PubMed/NCBI
|
|
8
|
Friedman HS, Kerby T and Calvert H:
Temozolomide and treatment of malignant glioma. Clin Cancer Res.
6:2585–2597. 2000.PubMed/NCBI
|
|
9
|
Agarwala SS and Kirkwood JM: Temozolomide,
a novel alkylating agent with activity in the central nervous
system, may improve the treatment of advanced metastatic melanoma.
Oncologist. 5:144–151. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
O'Neal DP, Hirsch LR, Halas NJ, Payne JD
and West JL: Photo-thermal tumor ablation in mice using near
infrared-absorbing nanoparticles. Cancer Lett. 209:171–176. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang J and Chen YC: Nanomaterials for
photohyperthermia: A review. Curr Pharm Des. 19:6622–6634. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W, Guo Z, Huang D, Liu Z, Guo X and
Zhong H: Synergistic effect of chemo-photothermal therapy using
PEGylated graphene oxide. Biomaterials. 32:8555–8561. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang H, Sun Y, Huang R, Cang H, Cai Z and
Sun B: pH-sensitive prodrug conjugated polydopamine for
NIR-triggered synergistic chemo-photothermal therapy. Eur J Pharm
Biopharm. 128:260–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen R, Zheng X, Qian H, Wang X, Wang J
and Jiang X: Combined near-IR photothermal therapy and chemotherapy
using gold-nanorod/chitosan hybrid nanospheres to enhance the
antitumor effect. Biomater Sci. 1:285–293. 2013. View Article : Google Scholar
|
|
15
|
El-Sayed IH, Huang X and El-Sayed MA:
Selective laser photo-thermal therapy of epithelial carcinoma using
anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett.
239:129–135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang X, Jain PK, El-Sayed IH and El-Sayed
MA: Plasmonic photothermal therapy (PPTT) using gold nanoparticles.
Lasers Med Sci. 23:217–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wiley BJ, Chen Y, McLellan JM, Xiong Y, Li
ZY, Ginger D and Xia Y: Synthesis and optical properties of silver
nanobars and nanorice. Nano Lett. 7:1032–1036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirsch LR, Gobin AM, Lowery AR, Tam F,
Drezek RA, Halas NJ and West JL: Metal nanoshells. Ann Biomed Eng.
34:15–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Conde J, Doria G and Baptista P: Noble
metal nanoparticles applications in cancer. J Drug Deliv.
2012:7510752012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Lu W, Huang Q, Li C and Chen W:
Copper sulfide nanoparticles for photothermal ablation of tumor
cells. Nanomedicine (Lond). 5:1161–1171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Robinson JT, Tabakman SM, Liang Y, Wang H,
Casalongue HS, Vinh D and Dai H: Ultrasmall reduced graphene oxide
with high near-infrared absorbance for photothermal therapy. J Am
Chem Soc. 133:6825–6831. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao J, Gu H and Xu B: Multifunctional
magnetic nanoparticles: Design, synthesis, and biomedical
applications. Acc Chem Res. 42:1097–1107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee S, George Thomas R, Ju Moon M, Ju Park
H, Park IK, Lee BI and Yeon Jeong Y: Near-infrared heptamethine
cyanine based iron oxide nanoparticles for tumor targeted
multimodal imaging and photothermal therapy. Sci Rep. 7:21082017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen S, Kong F, Guo X, Wu L, Shen H, Xie
M, Wang X, Jin Y and Ge Y: CMCTS stabilized Fe3O4 particles with
extremely low toxicity as highly efficient near-infrared
photothermal agents for in vivo tumor ablation. Nanoscale.
5:8056–8066. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sadat M, Kaveh Baghbador M, Dunn AW,
Wagner HP, Ewing CR, Zhang J, Xu H, Pauletti GM, Mast DB and Shi D:
Photoluminescence and photothermal effect of
Fe3O4 nanoparticles for medical imaging and
therapy. Appl Phys Lett. 105:0919032014. View Article : Google Scholar
|
|
26
|
Chen H, Burnett J, Zhang F, Zhang J,
Paholak H and Sun D: Highly crystallized iron oxide nanoparticles
as effective and biodegradable mediators for photothermal cancer
therapy. J Mater Chem B. 2:757–765. 2014. View Article : Google Scholar
|
|
27
|
Yuan G, Yuan Y, Xu K and Luo Q:
Biocompatible PEGylated Fe3O4 nanoparticles
as photothermal agents for near-infrared light modulated cancer
therapy. Int J Mol Med Sci. 15:18776–18788. 2014. View Article : Google Scholar
|
|
28
|
Zhang Y: Photothermal effect of PS coated
Fe3O4 nanoparticles via near-infrared laser and effect of mimic
body tissue depth on hyperthermic ablation of MDA-MB-231Univ
Cincinnati; 2015
|
|
29
|
Baronzio G, Parmar G, Ballerini M, Szasz
A, Baronzio M and Cassutti V: A brief overview of hyperthermia in
cancer treatment. J Integr Oncol. 3:1152014. View Article : Google Scholar
|
|
30
|
Fernandes C, Suares D and Yergeri MC:
Tumor microenvironment targeted nanotherapy. Front Pharmacol.
9:12302018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Siemann DW: The unique characteristics of
tumor vasculature and preclinical evidence for its selective
disruption by tumor-vascular disrupting agents. Cancer Treat Rev.
37:63–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahmed K and Zaidi SF: Treating cancer with
heat: Hyperthermia as promising strategy to enhance apoptosis. J
Pak Med Assoc. 63:504–508. 2013.PubMed/NCBI
|
|
33
|
Melamed JR, Edelstein RS and Day ES:
Elucidating the fundamental mechanisms of cell death triggered by
photothermal therapy. ACS Nano. 9:6–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
May JP and Li SD: Hyperthermia-induced
drug targeting. Expert Opin Drug Deliv. 10:511–527. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song C, Park H, Lee C and Griffin R:
Implications of increased tumor blood flow and oxygenation caused
by mild temperature hyperthermia in tumor treatment. Int J
Hyperthermia. 21:761–767. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao Z, Liu X, Liu Y, Liu H and Zhao K:
Near-infrared light-responsive inorganic nanomaterials for
photothermal therapy. Asian J Pharm Sci. 11:349–364. 2016.
View Article : Google Scholar
|
|
37
|
Zheng X, Zhou F, Wu B, Chen WR and Xing D:
Enhanced tumor treatment using biofunctional indocyanine
green-containing nanostructure by intratumoral or intravenous
injection. Mol Pharm. 9:514–522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xie J, Peng S, Brower N, Pourmand N, Wang
SX and Sun S: One-pot synthesis of monodisperse iron oxide
nanoparticles for potential biomedical applications. Pure Appl
Chem. 78:1003–1014. 2006. View Article : Google Scholar
|
|
39
|
Jiang L, Zhou X, Wei G, Lu X, Wei W and
Qiu J: Preparation and characterization of poly(glycidyl
methacrylate)-grafted magnetic nanoparticles: Effects of the
precursor concentration on polyol synthesis of
Fe3O4 and [PMDETA]0/[CuBr2]0 ratios on
SI-AGET ATRP. Appl Surf Sci. 357:1619–1624. 2015. View Article : Google Scholar
|
|
40
|
Feng G, Jiang L, Wen P, Cui Y, Li H and Hu
D: A new ion-exchange adsorbent with paramagnetic properties for
the separation of genomic DNA. Analyst. 136:4822–4829. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li H, Shan Y, Qiao L, Dou A, Shi X and Xu
G: Facile synthesis of boronate-decorated polyethyleneimine-grafted
hybrid magnetic nanoparticles for the highly selective enrichment
of modified nucleosides and ribosylated metabolites. Anal Chem.
85:11585–11592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bertucci A, Prasetyanto EA, Septiadi D,
Manicardi A, Brognara E, Gambari R, Corradini R and De Cola L:
Combined delivery of temozolomide and anti-miR221 PNA using
mesoporous silica nanoparticles induces apoptosis in resistant
glioma cells. Small. 11:5687–5695. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Razak AA, Masthanamma S, Omshanthi B,
Suresh V and Obulamma P: Development and validation of UV method of
temozolomide in bulk and capsule formulation. Int J Pharm Sci Res.
4:14192013.
|
|
44
|
Ma Y, Tong S, Bao G, Gao C and Dai Z:
Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG
coating for dual-modal imaging and photothermal therapy.
Biomaterials. 34:7706–7714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim JH, Ramasamy T, Tran TH, Choi JY, Cho
HJ, Yong CS and Kim JO: Polyelectrolyte complex micelles by
self-assembly of polypeptide-based triblock copolymer for
doxorubicin delivery. Asian J Pharm Sci. 9:191–198. 2014.
View Article : Google Scholar
|
|
46
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Niu C, Xu Y, An S, Zhang M, Hu Y, Wang L
and Peng Q: Near-infrared induced phase-shifted
ICG/Fe3O4 loaded PLGA nanoparticles for
photothermal tumor ablation. Sci Rep. 7:54902017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Eruslanov E and Kusmartsev S:
Identification of ROS using oxidized DCFDA and flow-cytometry.
Advanced protocols in oxidative stress II Springer. 57–72. 2010.
View Article : Google Scholar
|
|
49
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sanfilippo S, Canis M, Ouchchane L,
Botchorishvili R, Artonne C, Janny L and Brugnon F: Viability
assessment of fresh and frozen/thawed isolated human follicles:
Reliability of two methods (Trypan blue and Calcein AM/ethidium
homodimer-1). J Assist Reprod Genet. 28:1151–1156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhou S, Cui Z and Urban J: Dead cell
counts during serum cultivation are underestimated by the
fluorescent live/dead assay. Biotechnol J. 6:513–518. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tawakoli PN, Al-Ahmad A, Hoth-Hannig W,
Hannig M and Hannig C: Comparison of different live/dead stainings
for detection and quantification of adherent microorganisms in the
initial oral biofilm. Clin Oral Investig. 17:841–850. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Grudzinski IP, Bystrzejewski M, Cywinska
MA, Kosmider A, Poplawska M, Cieszanowski A and Ostrowska A:
Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles
in melanoma cells and dermal fibroblasts. J Nanopart Res.
15:18352013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yan F, Wu H, Liu H, Deng Z, Liu H, Duan W,
Liu X and Zheng H: Molecular imaging-guided
photothermal/photodynamic therapy against tumor by iRGD-modified
indocyanine green nanoparticles. J Control Release. 224:217–228.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dong Z, Gong H, Gao M, Zhu W, Sun X, Feng
L, Fu T, Li Y and Liu Z: Polydopamine nanoparticles as a versatile
molecular loading platform to enable imaging-guided cancer
combination therapy. Theranostics. 6:1031–1042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Matés JM and Sánchez-Jiménez FM: Role of
reactive oxygen species in apoptosis: Implications for cancer
therapy. Int J Biochem Cell Biol. 32:157–170. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Aioub M, Panikkanvalappil SR and El-Sayed
MA: Platinum-coated gold nanorods: Efficient reactive oxygen
scavengers that prevent oxidative damage toward healthy, untreated
cells during plasmonic photothermal therapy. ACS Nano. 11:579–586.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Oliva CR, Moellering DR, Gillespie GY and
Griguer CE: Acquisition of chemoresistance in gliomas is associated
with increased mitochondrial coupling and decreased ROS production.
PLoS One. 6:e246652011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu B, Li C, Xing B, Yang P and Lin J:
Multifunctional simpleUCNPs@PDA-ICG nanocomposites
for upconversion imaging and combined photothermal/photodynamic
therapy with enhanced antitumor efficacy. J Mater Chem B.
4:4884–4894. 2016. View Article : Google Scholar
|
|
61
|
Stupp R, van den Bent MJ and Hegi ME:
Optimal role of temozolomide in the treatment of malignant gliomas.
Curr Neurol Neurosci Rep. 5:198–206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Samali A, Holmberg CI, Sistonen L and
Orrenius S: Thermotolerance and cell death are distinct cellular
responses to stress: Dependence on heat shock proteins. FEBS Lett.
461:306–310. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Reed JC: Apoptosis-targeted therapies for
cancer. Cancer Cell. 3:17–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mohammadinejad R, Moosavi MA, Tavakol S,
Vardar DÖ, Hosseini A, Rahmati M, Dini L, Hussain S, Mandegary A
and Klionsky DJ: Necrotic, apoptotic and autophagic cell fates
triggered by nanoparticles. Autophagy. 15:4–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Mocan L, Matea C, Tabaran FA, Mosteanu O,
Pop T, Mocan T and Iancu C: Photothermal treatment of liver cancer
with albumin-conjugated gold nanoparticles initiates Golgi
Apparatus-ER dysfunction and caspase-3 apoptotic pathway activation
by selective targeting of Gp60 receptor. Int J Nanomed.
10:5435–5445. 2015.
|
|
67
|
Hongmei Z: Extrinsic and intrinsic
apoptosis signal pathway review. Apoptosis and Medicine In Tech
Open. 2012. View
Article : Google Scholar
|
|
68
|
Haupt S, Berger M, Goldberg Z and Haupt Y:
Apoptosis-the p53 network. J Cell Sci. 116:4077–4085. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Perfettini JL, Reed JC, Israël N, Martinou
JC, Dautry-Varsat A and Ojcius DM: Role of Bcl-2 family members in
caspase-independent apoptosis during Chlamydia infection. Infect
Immun. 70:55–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yee C, Yang W and Hekimi S: The intrinsic
apoptosis pathway mediates the pro-longevity response to
mitochondrial ROS in C. elegans. Cell. 157:897–909. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Andón FT and Fadeel B: Programmed cell
death: Molecular mechanisms and implications for safety assessment
of nanomaterials. Acc Chem Res. 46:733–742. 2012. View Article : Google Scholar : PubMed/NCBI
|
